Diagnostic Kits/Testing new ground
Jump to navigation
Jump to search
- Field of Molecular Diagnostics is expanding from disease detection to include Prognostics (prediction of disease risk) and tests for a patients response to treatment. Lots of discoveries of new genetic targets and biomarkers enabled by genomics and proteomics.
- Biomarkers may be indicators of disease as well as potential drug targets
- Molecular Diagnostic market revenue: 2001- $1.2B; 2007- $4.2B? (actually an over-optimistic estimate)